Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0421 per EA under NDC 82009003510. Its NADAC has been published 164 times since May 10, 2023.
Strength
5 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009003510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA090939On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 164 times since May 10, 2023, and over the history we have for it it has declined 6.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0421 per EA |
|---|---|
| All-time high | $0.0501 (Apr 10, 2024) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0474 |
| 52-week low | $0.0412 |
| Median price | $0.0455 |
| Average price | $0.0441 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 164 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the escitalopram oxalate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0421 per EA (NDC 82009003510), effective Jun 24, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 6.4%. It has been tracked across 164 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since May 10, 2023, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0455 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ESCITALOPRAM 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 82009003510) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification